NL-OMON35700尚未招募4 期
What is the Optimal antiplatElet & anticoagulant therapy in patients with oral anticoagulation and coronary StenTing - WOEST Trial:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 496
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patient under warfarin treatment such as patients with atrial fibrillation, mechanical valve... AND with indication for percutaneous coronary intervention
排除标准
- •cardiogenic shock, contra-indication for aspirin or clopidogrel, documented peptic ulcer disease within the previous six months, pregnancy and previous intracerebral haemorrhage or significant thrombocytopenia (platelet count < 50x10 9/L).
研究者
相似试验
进行中（未招募）
1 期
Optimal anticoagulation for patients with an increased risk for stroke after treatment of an heart arrhythmia (atrial fibrillation) by catheter ablatiorisk of stroke by atrial fibrillationMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 22.1Level: PTClassification code 10014498Term: Embolic strokeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10059864Term: Cardiac ablationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2016-002353-38-DEOttawa Heart Institute Research Corporation (OHIRC)1,572
进行中（未招募）
1 期
OCEAEUCTR2016-002353-38-BEOttawa Heart institute Research Corporation1,284
已完成
4 期
WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)AnticoagulantsPlatelet Aggregation InhibitorsStentsAtrial FibrillationNCT00769938R&D Cardiologie573
已完成
不适用
Study of Real World Anticoagulation and Antiplatelet Practice in Patients with Acute Coronary Syndrome Complicated with Atrial fibrillatioAtrial fibrillation combined acute coronary syndromeJPRN-UMIN000027356Juntendo University Department of Cardiovascular Medicine, Graduate School of Medicine460
招募中
4 期
Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing
Device Thrombosis Following Left Atrial Appendage Closure. The ANDES
study.2025-520954-12-00Centre Hospitalier Universite De Laval250